Stocks and Investing
Stocks and Investing
Wed, April 29, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, April 28, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Initiated (ADVM) at Strong Buy and Held Target at $170 on, Apr 28th, 2020
Graig Suvannavejh of Goldman Sachs, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Strong Buy and Held Target at $170 on, Apr 28th, 2020.
Graig has made no other calls on ADVM in the last 4 months.
There are 4 other peers that have a rating on ADVM. Out of the 4 peers that are also analyzing ADVM, 0 agree with Graig's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Graig
- Mani Foroohar of "SVB Leerink" Initiated at Buy and Held Target at $170 on, Monday, March 16th, 2020
- Alethia Young of "Cantor Fitzgerald" Upgraded from Hold to Buy and Increased Target to $210 on, Monday, February 10th, 2020
- Gbola Amusa of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $200 on, Monday, February 10th, 2020
- Tyler Van Buren of "Piper Sandler" Reiterated at Buy with Increased Target to $200 on, Monday, January 13th, 2020